Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis. - sprookjes - yvandenbroek - TriplyDB

Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.

Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.

http://www.wikidata.org/entity/Q34396945

about

IL-32θ negatively regulates IL-1β production through its interaction with PKCδ and the inhibition of PU.1 phosphorylation Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production IL-32-induced Inflammatory Cytokines Are Selectively Suppressed by α1-antitrypsin in Mouse Bone Marrow Cells.Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.Interleukin-32 in inflammatory autoimmune diseases.IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha Abnormal epigenetic changes during differentiation of human skeletal muscle stem cells from obese subjects.Intracellular interaction of interleukin (IL)-32α with protein kinase Cε (PKCε ) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells.Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32β overexpressed transgenic mice.Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.IL-32α-induced inflammation constitutes a link between obesity and colon cancer.A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation.Interleukin-32γ suppresses allergic airway inflammation in mouse models of asthma.Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review.TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea Interleukin-32α Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis.Interleukin-32β ameliorates metabolic disorder and liver damage in mice fed high-fat diet.Interleukin-32γ attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses.Neuroinflammatory and Amyloidogenic Activities of IL-32β in Alzheimer's Disease.Reducing effect of IL-32α in the development of stroke through blocking of NF-κB, but enhancement of STAT3 pathways.Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.Role of interleukin-32 in cancer biology.Role of IL-32 Gamma on Bone Metabolism in Autoimmune Arthritis.Interleukin-32: its role in asthma and potential as a therapeutic agent.IL-32γ attenuates airway fibrosis by modulating the integrin-FAK signaling pathway in fibroblasts

P2860

Q24300286-B71EBB4C-DCDD-4101-9157-DB3352256A47 Q24317887-4D63A93A-3BCC-4257-BDA6-8DDDFF24CD1E Q33611313-0F7063F0-9605-4C95-9620-A21214B06E8C Q33633481-10A14C8E-AC94-49C9-A10E-9D7FC0C39CAF Q33838804-49A2E9DF-520B-45F8-ADA2-1D15A9F051C3 Q33909932-6F707067-C5B7-4C33-B319-DDD6AAB5D0DE Q34720467-5C862C2C-1B5B-4655-993F-9684789C2ADB Q34995534-6AAB5BC2-910F-47A8-A817-EC3B06139D75 Q35134651-172152F2-80F9-42D0-BF15-00BAA03A9DE8 Q35469357-DD180D02-618C-439B-85A2-B55CC806D4FD Q35549372-094E2609-2B54-4043-903B-35BFCD33ADF7 Q36246023-859FA661-490D-4D2E-8DBE-5ED99163BE0C Q36286814-0CAD5339-A8C2-41C6-928C-D9022F299EFC Q36318831-82C3301D-5E89-4595-9770-7270B568BEFF Q36562052-CC3731A5-9DA0-4E06-9D33-ADE7499ED6C0 Q36629365-C2DC3CE5-2272-485E-B775-5ED37BAE251F Q37581596-3E232873-8C67-4204-874E-83A5F573EAE1 Q38287509-3A5F9CA9-336B-44C1-9E02-394AFA26AB22 Q38334454-DDB7AB22-EBD9-4DCB-99E2-9DE3C0E9C0AB Q38443719-361974AE-000B-4BF1-833E-0BDB0FEECA62 Q38791725-DDD6EF70-1172-4797-9536-C413523CD842 Q38901833-42266C08-534A-49D6-9CB6-6B4047CBBEC4 Q40980359-1BEE28FC-0EA7-43CA-B037-3F72C4221ACD Q41489654-4A57F3F9-070E-4762-8A80-FF36CED58661 Q41590316-69A33F9F-972E-4994-BB1F-DF31E089FB39 Q46700370-2872556D-C1D5-4831-AEBF-8890E7276F40 Q46891023-47D321CD-1744-41ED-99B9-AC262E16C942 Q52730248-11B6CCE4-7873-4124-AFB9-D9A27B82856A Q55264916-D2387BFB-71BC-42F4-948F-C69E5A06A39C Q55435298-CF5DF23E-AC8B-4351-8F91-25D07CFA79AF Q55479672-914BC1E5-6315-4CB3-A2B2-437B7250C080 Q58694819-004F672B-CA9B-4145-86C1-B8E89B11C5A9

P2860

Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.

http://www.wikidata.org/entity/Q34396945

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Paradoxical effects of constit ...... e during experimental colitis.

@ast

Paradoxical effects of constit ...... e during experimental colitis.

@en

Paradoxical effects of constit ...... e during experimental colitis.

@nl

type

label

Paradoxical effects of constit ...... e during experimental colitis.

@ast

Paradoxical effects of constit ...... e during experimental colitis.

@en

Paradoxical effects of constit ...... e during experimental colitis.

@nl

prefLabel

Paradoxical effects of constit ...... e during experimental colitis.

@ast

Paradoxical effects of constit ...... e during experimental colitis.

@en

Paradoxical effects of constit ...... e during experimental colitis.

@nl

P1433

Q34396945-A99CE143-810E-4DE2-AAFA-2A9C2407EC1C

P1476

Q34396945-CE5F3012-8E60-4BF8-BC75-33C4BAFAAAF8

P2093

Q34396945-042237EA-391D-4312-8DD0-3D7229F45E4A

Q34396945-1316392B-056C-44C5-856C-D3395450DB51

Q34396945-40E732AE-FAC5-4E3E-A8B8-9E5791403FAF

Q34396945-5EB522EF-2F79-429C-BD20-F9ABE8246806

Q34396945-6AA7EE2E-0FD6-457A-9E5E-5EA3B7DDB14A

Q34396945-8FD7E355-6931-4216-B438-D28818E2BB7E

Q34396945-9F5378FE-0427-401B-87B6-A1F4AD6D441D

Q34396945-A94A3213-361E-49F0-8863-731AFDC5E4BE

Q34396945-C597A9F4-6665-4036-AA4B-4227EF17B3AF

Q34396945-DB614EAD-17CA-4B3F-A497-27F43B02386F

P2860

Q34396945-04DB785B-7166-4CEA-B006-9C6FD89145C2

Q34396945-1F81CE46-C299-4CC4-8AA8-00FFC8EEE15C

Q34396945-2793BB38-FF59-410D-B434-15E45162B9A4

Q34396945-382358CE-E06C-4344-B01B-EF4D6E5EC519

Q34396945-48ECE5F8-2DA2-450B-A3F1-4142AF6D9678

Q34396945-666D6180-FB1E-437A-ADFC-50FDD2C4DA30

Q34396945-6847E263-A555-4417-97EA-0FC4AEC009E2

Q34396945-6AD4BF0A-64D2-4F62-BE86-7BBA00F5FC53

Q34396945-7EFDAF3D-C1ED-4949-BF05-96AA7803CBE0

Q34396945-85B4ABA8-97AE-4FF5-8248-E3F8605AA1C2

P304

Q34396945-43D2230C-9719-4ED1-99A4-35E0FFDD0669

P31

Q34396945-0060C777-5426-4A86-A86F-F0919F5BF6CF

P356

Q34396945-5F6EDE7F-CDBA-4D8F-B659-54FDF08FC0E1

P407

Q34396945-4F528BE5-DA3D-469C-B489-761A331B2DA4

P433

Q34396945-52843DC9-C4F8-41A6-99C2-816DD058AA3C

P478

Q34396945-EB611234-9587-424E-92E5-59DB6AFE9C1C

P50

Q34396945-295E09AE-3A81-44A5-A57B-12DC9C8476B7

P577

Q34396945-6475C342-F4C0-4E79-8845-2081AC7C8570

P5875

Q34396945-7CC9B4B7-D9EA-4A33-B592-A7DB9C668D23

P698

Q34396945-112D1EAD-1DF7-4CBD-AEAF-A977C8D6D0B9

P932

Q34396945-B69DF5FD-4563-4367-B1D6-334EEC77489E

P356

PNAS.1015418107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Paradoxical effects of constit ...... e during experimental colitis.

@en

P2093

Doyoung Yoon

http://www.w3.org/2001/XMLSchema#string

Erk Her

http://www.w3.org/2001/XMLSchema#string

Hyunjhung Jhun

http://www.w3.org/2001/XMLSchema#string

Jaewoo Hong

http://www.w3.org/2001/XMLSchema#string

Jeonghwan Kim

http://www.w3.org/2001/XMLSchema#string

Jida Choi

http://www.w3.org/2001/XMLSchema#string

Kwangwon Hong

http://www.w3.org/2001/XMLSchema#string

Siyoung Lee

http://www.w3.org/2001/XMLSchema#string

Soohyun Kim

http://www.w3.org/2001/XMLSchema#string

Soyoon Ryoo

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-10 and the interleukin-10 receptor

IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism

Interleukin-32: a cytokine and inducer of TNFalpha

Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract

Cytokine therapy for Crohn's disease: advances in translational research.

IL-32: an emerging player in the immune response network against tuberculosis?

Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model.

TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis.

IL-32, a proinflammatory cytokine in rheumatoid arthritis.

P304

21082-21086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1015418107

http://www.w3.org/2001/XMLSchema#string

P407

P433

49

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Charles A. Dinarello

P577

2010-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47794344

http://www.w3.org/2001/XMLSchema#string

P698

21078994

http://www.w3.org/2001/XMLSchema#string

P932

3000248

http://www.w3.org/2001/XMLSchema#string